Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

To the best of our knowledge, the clinical implications of using ribonucleoside reductase subunit M1 (RRM1) in patients who undergo curative resection and adjuvant chemotherapy have not been established. In the present study, the clinical data from 101 consecutive patients who underwent macroscopica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Autores principales: Aoyama, Toru, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5431334/
https://ncbi.nlm.nih.gov/pubmed/28521448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5935
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares